Epic Research

Monday, February 11, 2013

Epic Update : Dr Reddy’s Laboratories

Dr Reddy’s Laboratories has launched Desloratadine Orally Disintegrating Tablets (ODT) (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex Reditabs (desloratadine) in the US market on January 24, 2013. Dr Reddy’s ANDA for Desloratadine ODT is approved by the United States Food & Drug Administration (USFDA).

Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips.

No comments:

Post a Comment